|
1
|
Salha LA, Reis FC, Gonçalves RM, Lima JHDS, Salha NA, Pinto RP, de Menezes JE, Oliveira EP, Ferreira PL, Barbosa MA. Judicialization of health: profile of demands for oncological medicines in a state in the central region of Brazil. Int J Equity Health 2022; 21:112. [PMID: 35978319 PMCID: PMC9387029 DOI: 10.1186/s12939-022-01704-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Accepted: 07/13/2022] [Indexed: 12/24/2022] Open
Abstract
BACKGROUND The significant increase in access to oncological medicines through court cases suggests that constitutional guarantees of integral and universal care in the Brazilian public health system are uncertain. METHODS A retrospective observational study was conducted to analyze data from lawsuits requesting oncological medicines from 2014 to 2020 in the State of Goiás, Brazil, in state and federal courts. Sociodemographic, medical, and legal variables were statistically examined using descriptive, association, and correlation methods. RESULTS Women brought more than half (54%) of the 301 processes analyzed. The most frequent age group was over 55 years, with income below 3 × the minimum wage (total about USD$600/month), and their cases were promoted through the public minister and public defender's offices. The most requested medications, not on official public health system lists, were indicated for multiple myeloma and brain cancer. CONCLUSIONS Improved quality of life, frequently used as a justification, could be conceptually confused with increased survival. Finally, judicialization itself indicates that individual health needs arise even with properly defined and adequately implemented public policies. These needs should be considered for the adequate provisioning of services by the state to ensure the right to health.
Collapse
Affiliation(s)
- Leila Abou Salha
- Faculty of Medicine, Federal University of Goiás, Goiania, Goiás, 74605-050, Brazil.
| | - Flávia Costa Reis
- School of Law, Business and Communication, Pontifical Catholic University of Goiás, Goiania, Goiás, 74805-100, Brazil
| | | | | | - Nádia Abou Salha
- Physician, Petrópolis Medical School, Petrópolis, Rio de Janeiro, 25680-120, Brazil
| | - Roney Pereira Pinto
- State Health Department, Center for High-Cost Medicines Juarez Barbosa, Goiânia, Goiás, 74015-020, Brazil
| | - José Elmo de Menezes
- Federal Institute of Education, Science, and Technology of Goiás, Pontifical Catholic University of Goiás, Goiania, Goiás, 74605-900, Brazil
| | | | - Pedro Lopes Ferreira
- Center for Health Studies and Research, Faculty of Economics, University of Coimbra, 3004-512, Coimbra, Portugal
| | - Maria Alves Barbosa
- Faculty of Medicine, Federal University of Goiás, Goiania, Goiás, 74605-050, Brazil
| |
Collapse
|
|
2
|
Lima JHDS. Saúde global e política externa brasileira: negociações referentes à inovação e propriedade intelectual. Ciênc saúde coletiva 2017; 22:2213-2221. [DOI: 10.1590/1413-81232017227.02652017] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2016] [Accepted: 11/28/2016] [Indexed: 11/22/2022] Open
Abstract
Resumo Após a entrada em vigor do Acordo sobre Direitos de Propriedade Intelectual relacionados ao Comércio (Trips), o Brasil, assim como outros países em desenvolvimento, se tornou mais assertivo nas negociações multilaterais e passou a defender que o atual sistema internacional de propriedade intelectual fosse mais bem adaptado às suas necessidades e interesses. Ao fazê-lo, o país tem ressaltado que a propriedade intelectual não é tema associado exclusivamente ao comércio, mas também à saúde pública e aos direitos humanos. Sendo assim, o presente estudo propõe-se a analisar a atuação do governo brasileiro no âmbito de negociações multilaterais que envolvem saúde pública, inovação e propriedade intelectual. Ao resgatar a memória da atuação da diplomacia brasileira nessa área específica, conclui-se que o Brasil vem protagonizando esse debate, buscando alternativas que mitiguem os efeitos deletérios do atual sistema internacional de propriedade intelectual no acesso a medicamentos e outras tecnologias médicas nos países em desenvolvimento.
Collapse
|